BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2000
View Archived Issues
Avant Immunotherapeutics to acquire Megan Health
Read More
Favorable pharmacokinetic and tolerability profile for Angiozyme in humans
Read More
Repligen reports update on product development programs
Read More
VX-175 enters series of phase III trials
Read More
Dusa moves Levulan into phase I/II for the treatment of acne
Read More
TP-10 undergoes phase II evaluation in adult cardiac surgery patients
Read More
NicOx's HCT-1026 shows promise for treatment of skin inflammation
Read More
Virax's HIV vaccine VIR-201 approved for human study
Read More
Company Profile: EpiCept
Read More
Acadia succeeds in designing selective 5-HT2A inverse agonists/antagonists based on spiperone
Read More
Yamanouchi discovers novel class of potent, nonsteroidal human 5alpha-reductase inhibitors
Read More
Phytomedicine continues to show promise for GI inflammatory conditions
Read More
Synthetic immunomodulatory peptide inhibits production of proinflammatory cytokines in CD
Read More
PK-11195 is able to sensitize cholangiocarcinoma cells to radiation-induced apoptosis
Read More
Immediate withdrawal of Lotronex in U.S. announced by Glaxo Wellcome
Read More
Amarin licenses U.S. rights to LAX-101 for Huntington's disease
Read More
8th UEGW news: alendronate is safe and effective for increasing BMD in Crohn's disease
Read More
Fampridine-SR enters phase II trials for MS
Read More
Successful completion of Alkermes' first clinical trial with inhaled insulin
Read More
Enhanced expression of p21 associated with responses to rAd-p53 gene therapy in NSCLC
Read More
Anticoagulants targeting thrombin developed at ADIR
Read More
Novel series of cognition enhancers claimed in recent patent by ADIR
Read More
Fujisawa synthesizes cyclic hexapeptides with broad-spectrum antifungal activity
Read More
Piperidine-based renin inhibitors and their use described by Roche
Read More
Integrin alpha4beta1 inhibitors disclosed by AstraZeneca scientists
Read More
Tri- and di-aryl acid PPAR modulators claimed by Aventis for diabetes and related disorders
Read More
Lyotropic Therapeutics and Elan establish alliance for development of unique drug delivery system
Read More